Expertise in
13
conditions

Dr. Elyse Rafal

Dermatology
Elyse S. Rafal MD PC
2500 Nesconset Hwy Bldg 22A, 
Stony Brook, NY 
Referral may be required
Expertise in
13
conditions
Elyse S. Rafal MD PC
2500 Nesconset Hwy Bldg 22A, 
Stony Brook, NY 

Overview

Elyse Rafal is a Dermatologist practicing medicine in Stony Brook, New York.

Dr. Rafal is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Acne, Epidermoid Cyst, Liver Spots, and Universal Acquired Melanosis.

She is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 7 clinical trials.

Specialties

Dermatology

Licenses

Dermatology in NY

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Nippon Life
  • INSURANCE PLAN
Northwell Health
  • INSURANCE PLAN
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Elyse S. Rafal MD PC
2500 Nesconset Hwy Bldg 22A, Stony Brook, NY 11790

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE AD2) - A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE AD2) - A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 04, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
Enrollment Status: Completed
Publish Date: November 20, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

4 Total Publications

Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.
Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.
Journal: Dermatology and therapy
Published: January 12, 2024
Similar Doctors
Expertise in
22
conditions
Dr. Ashfaq Marghoob
Dermatology
Expertise in
22
conditions
Dr. Ashfaq Marghoob
Dermatology
Referral may be required

Memorial Sloan Kettering Skin Cancer Center Hauppauge

800 Veterans Memorial Hwy, 
Hauppauge, NY 
 (6.2 miles away)
607-203-2419
Languages Spoken:
English
See accepted insurances

Ashfaq Marghoob is a Dermatologist practicing medicine in Hauppauge, New York. Dr. Marghoob is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Melanoma, Familial Atypical Multiple Mole Melanoma Syndrome, and Seborrheic Keratosis.

Expertise in
17
conditions
Dr. Leon Kircik
Dermatology
Expertise in
17
conditions
Dr. Leon Kircik
Dermatology
Referral may be required

MSSM-Optical Shop

17 E 102nd St, 
New York, NY 
 (44.2 miles away)
212-659-8554
Languages Spoken:
English
See accepted insurances

Leon Kircik is a Dermatologist practicing medicine in New York, New York. Dr. Kircik is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Acne, Plaque Psoriasis, Atopic Dermatitis, and Psoriasis.

Expertise in
11
conditions
Dr. Michael Girardi
Dermatology
Expertise in
11
conditions
Dr. Michael Girardi
Dermatology
Referral may be required

Yale Dermatology Associates PC

2 Church St S Ste 305, 
New Haven, CT 
 (30.2 miles away)
203-785-4632
Languages Spoken:
English
See accepted insurances

Michael Girardi is a Dermatologist practicing medicine in New Haven, Connecticut. Dr. Girardi is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Frequently Asked Questions about Dr. Elyse Rafal

How do I make an appointment with Dr. Elyse Rafal?

You can book an appointment with Dr. Elyse Rafal by calling their office at 631-689-0300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Elyse Rafal a top-rated expert for Acne?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Elyse Rafal is classified as an Advanced expert for Acne, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Elyse Rafal specialize in?

While Dr. Elyse Rafal is a Dermatology, they have specific expertise in Acne, Epidermoid Cyst, and Liver Spots. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Elyse Rafal participate in research or clinical trials?

Yes. Dr. Elyse Rafal has published 4 articles and abstracts on conditions like Acne. You can view a list of Dr. Elyse Rafal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Elyse Rafal accept my insurance?

Dr. Elyse Rafal accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 631-689-0300 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rafal's expertise for a condition
ConditionClose
      View All 13 Advanced Conditions
      View All 36 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile